狼疮性肾炎患者肠道菌群变化及代谢物硫酸吲哚酚分析
Analysis of Intestinal Flora and Indoxyl Sulfate in the Patients with Lupus Nephritis
DOI: 10.12677/ACM.2021.111034, PDF,   
作者: 苏 晗:青岛大学附属青岛市市立医院,山东 青岛;邢 倩*:青岛大学附属青岛市市立医院,风湿免疫科,山东 青岛
关键词: 狼疮性肾炎肠道菌群24 h尿蛋白定量硫酸吲哚酚Lupus Nephritis Intestinal Flora 24 h Urinary Protein Quantification Indoxyl Sulfate
摘要: 目的:分析狼疮性肾炎(Lupus nephritis, LN)患者与健康人群肠道菌群的结构及代谢产物差异,探讨肠道菌群在LN发病中的作用。方法:选取系统性红斑狼疮患者51例,分为狼疮性肾炎组(LN组) 27例和狼疮非肾炎组(N-LN组) 24例,另选取53例健康志愿者作为健康对照组(H组)。基于Illumina MiSeq平台分别对SLE患者和健康对照组的粪便样本进行Alpha多样性分析、Beta多样性分析以及属水平上的菌群差异性分析,采用ELISA双抗体夹心法测定SLE患者和健康对照组血清硫酸吲哚酚(IS)浓度,对LN患者的24h尿蛋白定量与其血清IS浓度进行Pearson相关性分析,采用受试者工作曲线(ROC曲线),根据最佳敏感性和特异性确定IS诊断界点。结果:LN组较健康对照组血IS浓度和肠杆菌含量均显著升高,差异有统计学意义(P < 0.05)。在LN患者中,24 h尿蛋白定量与血清IS浓度呈正相关(r = 0.86, P < 0.01)。结论:狼疮性肾炎患者存在肠道菌群失调,肠杆菌含量明显增加,相关代谢产物血清IS异常,可能参与LN发病。
Abstract: Objective: To analyze the structure and metabolites of intestinal flora in patients with lupus nephritis and healthy controls, and to explore the role of intestinal flora in the pathogenesis of LN. Methods: 51 patients with systemic lupus erythematosus were divided into the lupus nephritis group (group LN, n = 27) and the lupus non-glomerulonephritis group (group N-LN, n = 24), and 53 healthy volunteers were selected as the healthy control group (group H). Based on the IlluminaMiSeq platform, the fecal samples of SLE patients and healthy controls were analyzed by Alpha diversity analysis, Beta diversity analysis and flora difference analysis at genus level. The blood Indoxyl sulfate (IS) concentration in SLE patients and healthy controls was determined by ELISA double antibody sandwich method. The correlation between the 24 h urinary protein quantification and the blood IS concentration in LN patients was examined by the Pearson correlation test. The best cutoffs for the blood IS concentration in predicting a 24 h urinary protein quantification were determined with the receiver operating characteristic curve (ROC). Results: The blood IS concentration and the content of fecal Faecalibacterium in group LN were significantly higher than those in the healthy control group (P < 0.05). In patients with LN, the 24 h urinary protein quantification was positively correlated with the blood IS concentration (r = 0.86, P < 0.01). Conclusion: The patients with lupus nephritis have intestinal flora imbalance, the content of fecal Faecalibacterium is significantly increased, and the blood IS concentration is abnormal, which may be involved in the pathogenesis of LN.
文章引用:苏晗, 邢倩. 狼疮性肾炎患者肠道菌群变化及代谢物硫酸吲哚酚分析[J]. 临床医学进展, 2021, 11(1): 235-242. https://doi.org/10.12677/ACM.2021.111034

参考文献

[1] Almaani, S., Meara, A. and Rovin, B.H. (2017) Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology, 12, 825-835. [Google Scholar] [CrossRef
[2] Sonnenburg, J.L. and Backhed, F. (2016) Diet-Microbiota Interactions as Moderators of Human Metabolism. Nature, 535, 56-64. [Google Scholar] [CrossRef] [PubMed]
[3] Qin, J., Li, R., Raes, J., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65. [Google Scholar] [CrossRef] [PubMed]
[4] 李苗, 付冰冰, 等. 系统性红斑狼疮与肠道菌群的相关研究[J]. 新医学, 2016, 47(11): 735-741.
[5] Chu, S., Mao, X., Guo, H., et al. (2017) Indoxyl Sulfate Potentiates Endothelial Dysfunction via Reciprocal Role for Reactive Oxygen Species and RhoA/ROCK Signaling in 5/6 Nephrectomized Rats. Free Radical Research, 51, 237-252. [Google Scholar] [CrossRef] [PubMed]
[6] Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatology, 40, 1725. [Google Scholar] [CrossRef] [PubMed]
[7] 唐余燕, 贺海东. 肠道微生物群在慢性肾脏病中的作用机制研究进展[J]. 国际泌尿系统杂志, 2019(5): 957-961.
[8] Hevia, A., Milani, C., Lopez, P., et al. (2014) Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus. MBio, 5, e01548-01514. [Google Scholar] [CrossRef
[9] Li, Y., Wang, H.F., Li, X., et al. (2019) Disordered Intestinal Microbes Are Associated with the Activity of Systemic Lupus Erythematosus. Clinical Science, 133, 821-838. [Google Scholar] [CrossRef
[10] Azzouz, D., Omarbekova, A., Heguy, A., et al. (2019) Lupus Nephritis Is Linked to Disease-Activity Associated Expansions and Immunity to a Gut Commensal. Annals of the Rheumatic Diseases, 78, 947-956. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, H., Liao, X., Sparks, J.B., et al. (2014) Dynamics of Gut Microbiota in Autoimmune Lupus. Applied and Environmental Microbiology, 80, 7551-7560. [Google Scholar] [CrossRef
[12] Petersen, C. and Round, J.L. (2014) Defining Dysbiosis and Its Influence on Host Immunity and Disease. Cellular Microbiology, 16, 1024-1033. [Google Scholar] [CrossRef] [PubMed]
[13] D’amelio, P. and Sassi, F. (2018) Gut Microbiota, Immune System, and Bone. Calcified Tissue International, 102, 415-425. [Google Scholar] [CrossRef] [PubMed]
[14] Nowling, T.K. and Gilkeson, G.S. (2011) Mechanisms of Tissue Injury in Lupus Nephritis. Arthritis Research & Therapy, 13, 250. [Google Scholar] [CrossRef] [PubMed]
[15] Schmidt, T., Paust, H.J., Krebs, C.F., et al. (2015) Function of the Th17/Interleukin-17A Immune Response in Murine Lupus Nephritis. Arthritis & Rheumatology, 67, 475-487. [Google Scholar] [CrossRef] [PubMed]
[16] 陈独群, 胡伟新. 狼疮足细胞病: 一种特殊类型的狼疮性肾炎[J]. 肾脏病与透析肾移植杂志, 2017, 26(1): 72-75+94.
[17] Vaziri, N.D., Zhao, Y.Y. and Pahl, M.V. (2016) Altered Intestinal Microbial Flora and Impaired Epithelial Barrier Structure and Function in CKD: The Nature, Mechanisms, Consequences and Potential Treatment. Nephrology Dialysis Transplantation, 31, 737-746. [Google Scholar] [CrossRef] [PubMed]
[18] Ellis, R.J., Small, D.M., Vesey, D.A., et al. (2016) Indoxyl Sulphate and Kidney Disease: Causes, Consequences and Interventions. Nephrology (Carlton), 21, 170-177. [Google Scholar] [CrossRef] [PubMed]
[19] Bergstrom, J. and Lindholm, B. (1998) Malnutrition, Cardiac Disease, and Mortality: An Integrated Point of View. American Journal of Kidney Diseases, 32, 834-841. [Google Scholar] [CrossRef
[20] 唐小芳, 刘虹. 硫酸吲哚酚对心血管毒性作用的研究进展[J]. 中国临床新医学, 2019, 12(7): 697-701.
[21] 张发明, 李玥粪. 菌移植治疗炎症性肠病的争议[J]. 协和医学杂志, 2019, 10(3): 211-215.
[22] 王珊, 夏耿红, 何彦, 等. 氧化三甲胺分布特征及其与肠道菌群的关联性[J]. 南方医科大学学报, 2016, 36(4): 455-460.
[23] Kim, D., Yoo, S.A. and Kim, W.U. (2016) Gut Microbiota in Autoimmunity: Potential for Clinical Applications. Archives of Pharmacal Research, 39, 1565-1576. [Google Scholar] [CrossRef] [PubMed]
[24] Xu, M.Q., Cao, H.L., Wang, W.Q., et al. (2015) Fecal Microbiota Transplantation Broadening Its Application beyond Intestinal Disorders. World Journal of Gastroenterology, 21, 102-111. [Google Scholar] [CrossRef] [PubMed]
[25] Anwar, S., Bhandari, U., Panda, B.P., et al. (2018) Trigonelline Inhibits Intestinal Microbial Metabolism of Choline and Its Associated Cardiovascular Risk. Journal of Pharmaceutical and Biomedical Analysis, 159, 100-112. [Google Scholar] [CrossRef] [PubMed]
[26] Wikoff, W.R., Anfora, A.T., Liu, J., et al. (2009) Metabolomics Analysis Reveals Large Effects of Gut Microflora on Mammalian Blood Metabolites. Proceedings of the National Academy of Sciences of the United States of America, 106, 3698-3703. [Google Scholar] [CrossRef] [PubMed]
[27] Jones, J.D. and Burnett, P.C. (1974) Creatinine Metabolism in Humans with Decreased Renal Function: Creatinine Deficit. Clinical Chemistry, 20, 1204-1212. [Google Scholar] [CrossRef
[28] Dou, L., Sallee, M., Cerini, C., et al. (2015) The Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid. Journal of the American Society of Nephrology, 26, 876-887. [Google Scholar] [CrossRef
[29] Watanabe, H., Miyamoto, Y., Honda, D., et al. (2013) p-Cresyl Sulfate Causes Renal Tubular Cell Damage by Inducing Oxidative Stress by Activation of NADPH Oxidase. Kidney International, 83, 582-592. [Google Scholar] [CrossRef] [PubMed]
[30] Meert, N., Eloot, S., Schepers, E., et al. (2011) Comparison of Removal Capacity of Two Consecutive Generations of High-Flux Dialysers during Different Treatment Modalities. Nephrology Dialysis Transplantation, 26, 2624-2630. [Google Scholar] [CrossRef] [PubMed]
[31] Sirich, T.L., Luo, F.J., Plummer, N.S., et al. (2012) Selectively Increasing the Clearance of Protein-Bound Uremic Solutes. Nephrology Dialysis Transplantation, 27, 1574-1579. [Google Scholar] [CrossRef] [PubMed]